Basilea Pharmaceutica 2019 Investor Presentation

Revenue-generating biotech company focused on oncology, hospital antifungals, and hospital antibiotics. Basilea markets two anti-infective brands (Cresemba and Zevtera) and develops three oncology drug candidates, with a strong cash position and operations based in Basel, Switzerland.